DIFFUSION PHARMACEUTICALS IN (DFFN) Forecast, Price Target & Analyst Ratings

NASDAQ:DFFN • US2537484048

Current stock price

4.4 USD
+0.46 (+11.68%)
At close:
4.46 USD
+0.06 (+1.36%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DIFFUSION PHARMACEUTICALS IN (DFFN).

Forecast Snapshot

Consensus Price Target

Price Target
$40.80
+ 827.27% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 13, 2023
Period
Q3 / 2023
EPS Estimate
-$1.99
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$40.80
Upside
+ 827.27%
From current price of $4.40 to mean target of $40.80, Based on 7 analyst forecasts
Low
$40.40
Median
$40.80
High
$42.00

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for DFFN. The average price target is 40.8 USD. This implies a price increase of 827.27% is expected in the next year compared to the current price of 4.4.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

DFFN Current Analyst RatingDFFN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

DFFN Historical Analyst RatingsDFFN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
DFFN was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about DFFN.
In the previous month the buy percentage consensus was at a similar level.
DFFN was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2022-08-16HC Wainwright & Co.Upgrade Neutral -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 13, 2023
Period
Q3 / 2023
EPS Estimate
-$1.99
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-45.18%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

DFFN is expected to report earnings on 11/13/2023. The consensus EPS estimate for the next earnings is -1.99 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
DFFN revenue by date.DFFN revenue by date.
N/AN/AN/AN/A
347.75%		N/A
61.48%		N/A
35.71%		N/A
24.89%		N/A
8.55%
EBITDA
YoY % growth
DFFN ebitda by date.DFFN ebitda by date.
-6.4M-18.34M
-186.56%		-11.28M
38.50%		-11.92M
-5.67%		-11.45M
3.94%		-15.872M
-38.62%		-15.945M
-0.46%		-15.972M
-0.17%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
DFFN ebit by date.DFFN ebit by date.
-6.41M-18.37M
-186.58%		-11.35M
38.21%		-12.03M
-5.99%		-11.55M
3.99%		-15.975M
-38.31%		-16.038M
-0.40%		-15.972M
0.41%		N/A
-12.40%		N/A
-8.52%		N/A
19.45%		N/A
58.95%		N/A
90.22%		N/A
769.14%		N/A
140.09%		N/A
25.46%
Operating Margin
DFFN operating margin by date.DFFN operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
DFFN eps by date.DFFN eps by date.
N/AN/AN/A-275.50
73.52%		-107.50
60.98%		-13.00
87.91%		-8.50
34.62%		N/A
4.84%		N/A
7.57%		N/A
13.10%		N/A
76.30%		N/A
59.60%		N/A
91.80%		N/A
900.00%		N/A
135.00%		N/A
25.53%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 23 Q4 / 23
EPS
Q2Q % growth		-1.99
-45.18%		-2.01
10.45%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/A
EBIT
Q2Q % growth		N/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

DFFN Yearly Revenue VS EstimatesDFFN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M
DFFN Yearly EPS VS EstimatesDFFN Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -200 -400 -600 -800 -1K

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
21.86%
EPS Next 5 Year
14.80%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

DIFFUSION PHARMACEUTICALS IN / DFFN Forecast FAQ

What do analysts expect the price target to be for DIFFUSION PHARMACEUTICALS IN (DFFN)?

7 analysts have analysed DFFN and the average price target is 40.8 USD. This implies a price increase of 827.27% is expected in the next year compared to the current price of 4.4.

When does DIFFUSION PHARMACEUTICALS IN (DFFN) report earnings?

DIFFUSION PHARMACEUTICALS IN (DFFN) will report earnings on 2023-11-13.

Can you provide the consensus estimates for DIFFUSION PHARMACEUTICALS IN next earnings?

The consensus EPS estimate for the next earnings of DIFFUSION PHARMACEUTICALS IN (DFFN) is -1.99 USD and the consensus revenue estimate is 0 USD.

How many analysts have analysed DIFFUSION PHARMACEUTICALS IN (DFFN)?

The number of analysts covering DIFFUSION PHARMACEUTICALS IN (DFFN) is 7.